Market Closed

GMAB
Genmab A/S
$ 51.37
-0.72%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Genmab A/S News

Latest Genmab A/S Stock News & GMAB Headlines

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
3 days ago | globenewswire.com
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
4 days ago | globenewswire.com
Capital Increase in Genmab as a Result of Employee Warrant Exercise
4 days ago | globenewswire.com
Genmab A/S (GMAB) Q3 2026 Earnings Call Transcript
9 days ago | seekingalpha.com
What Genmab A/S (GMAB) Said on Its Q3 Earnings Call
9 days ago | marketbeat.com
A little-known biotech's high-stakes cancer bet just paid off and its shares doubled
12 days ago | cnbc.com
Genmab A/S (GMAB) Discusses Phase III Cancer Data and Potential New Treatment Standards Transcript
17 days ago | seekingalpha.com
Genmab's Three Positive Phase III Readouts Set Stage for Potential 2027 Cancer Launches
17 days ago | marketbeat.com
Genmab Stock Hits 52-Week High - Here's Why
17 days ago | benzinga.com
Genmab Stock Surges to Record High as Cancer Drug Slashes Risk of Death by 50%
17 days ago | barrons.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

GMAB
Genmab A/S
$ 51.37
-0.72%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago